Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium

INTRODUCTION: Since 2010, 10-valent (PCV10) and 13-valent pneumococcal conjugate vaccines (PCV13) have been available as part of infant national immunization programs. Belgium is as one of the few countries that implemented PCV13 (2007–2015), switched to PCV10 (2015–2018) and then switched back to P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Michele R., McDade, Cheryl L., Perdrizet, Johnna E., Mignon, Annick, Farkouh, Raymond A., Wasserman, Matt D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322259/
https://www.ncbi.nlm.nih.gov/pubmed/34250576
http://dx.doi.org/10.1007/s40121-021-00485-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322259/
https://www.ncbi.nlm.nih.gov/pubmed/34250576
http://dx.doi.org/10.1007/s40121-021-00485-9

Ejemplares similares